- Home
- RXRX vs CDE Comparison
RXRX vs CDE Comparison
Compare RXRX & CDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- CDE
- Stock Information
- Founded
- RXRX 2013
- CDE 1928
- Country
- RXRX United States
- CDE United States
- Employees
- RXRX N/A
- CDE N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- CDE Precious Metals
- Sector
- RXRX Health Care
- CDE Basic Materials
- Exchange
- RXRX Nasdaq
- CDE Nasdaq
- Market Cap
- RXRX 2.6B
- CDE 2.5B
- IPO Year
- RXRX 2021
- CDE N/A
- Fundamental
- Price
- RXRX $5.29
- CDE $5.92
- Analyst Decision
- RXRX Buy
- CDE Strong Buy
- Analyst Count
- RXRX 4
- CDE 4
- Target Price
- RXRX $8.25
- CDE $8.00
- AVG Volume (30 Days)
- RXRX 17.5M
- CDE 19.9M
- Earning Date
- RXRX 05-08-2025
- CDE 04-30-2025
- Dividend Yield
- RXRX N/A
- CDE N/A
- EPS Growth
- RXRX N/A
- CDE N/A
- EPS
- RXRX N/A
- CDE 0.15
- Revenue
- RXRX $58,839,000.00
- CDE $1,054,006,000.00
- Revenue This Year
- RXRX $64.84
- CDE $50.28
- Revenue Next Year
- RXRX $55.98
- CDE $9.03
- P/E Ratio
- RXRX N/A
- CDE $39.47
- Revenue Growth
- RXRX 32.00
- CDE 28.35
- 52 Week Low
- RXRX $5.19
- CDE $4.03
- 52 Week High
- RXRX $12.36
- CDE $7.72
- Technical
- Relative Strength Index (RSI)
- RXRX 33.28
- CDE 46.95
- Support Level
- RXRX $6.27
- CDE $6.10
- Resistance Level
- RXRX $6.94
- CDE $6.53
- Average True Range (ATR)
- RXRX 0.38
- CDE 0.31
- MACD
- RXRX -0.06
- CDE 0.01
- Stochastic Oscillator
- RXRX 5.71
- CDE 27.98
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About CDE Coeur Mining Inc.
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada Mexico, and North America.